NMN: the language of "rejuvenation", and what human trials actually show

Human evidence: C (early, small, split results) Updated: October 2026

Summary: NMN is a substance that attracts attention in animal studies for metabolism and lifespan-related effects, but no human trial has established efficacy yet. Increases in blood NAD+-related markers and some improvements in small RCTs have been reported, but there is still no basis for claiming it "prevents aging" or "rejuvenates". Short-term safety data are reasonably good.

What NMN is — what it does

NMN (β-nicotinamide mononucleotide) is a precursor of NAD+, a coenzyme central to cellular energy metabolism and DNA repair, which declines with age. The idea that "replenishing NAD+ improves age-related function" is the starting point of this field; mouse studies have reported benefits for insulin sensitivity, eye function and physical capacity.

What human trials have shown

1. Improved muscle insulin sensitivity (Washington University, Science 2021)

A 10-week, double-blind, placebo-controlled RCT in 25 postmenopausal women with prediabetes. At 250 mg/day of NMN, muscle glucose disposal under insulin stimulation increased 25±7% (per lean kg, p<0.01). No change in liver or adipose insulin sensitivity, body weight or fasting glucose.

An important caveat. Published criticism of this trial notes that baseline liver fat was significantly higher in the placebo group (6.3% vs 14.8%) — i.e. randomization may have failed. It is a single small trial and replication is unconfirmed.

2. The Japanese trial cluster (2022 onward)

Trials by Japanese groups in older adults reported increased blood NAD+ metabolites and partial improvement in a 30-second chair-stand test at 250 mg/day for 12 weeks, but no effect on skeletal muscle index (SMI). Another Japanese trial (100–200 mg/day for 24 weeks) also found limited metabolic effects.

3. Blood NAD+ does rise. So what?

Across several trials, rises in blood NAD+-related metabolites are reproducibly observed — that is the near-certain proximate effect. But the chain "higher blood NAD+ → clinically meaningful health benefit" has not been proven in humans.

Safety

No serious adverse events have been reported in existing human trials (up to 250 mg/day for weeks to months). Animal studies report no significant side effects over more than a year of dosing. That is not the same as "long-term, high-dose safety is established".

Regulatory status (important)

In the United States, the FDA does not approve NMN as a treatment for any disease, and in 2022 it concluded NMN cannot be marketed as a dietary supplement because it was investigated as a pharmaceutical drug first. In Japan, a 2020 classification notice treats NMN as "not a drug so long as drug-like efficacy claims are not made" — which means the moment a product claims "anti-aging" or "rejuvenation", it becomes an unapproved drug. Supplements sold as food cannot carry efficacy claims; only products registered as Japan's Foods for Specified Health Uses may make their registered claim.

What to check before buying

Claims like "medically certified" or "FDA approved" — the FDA has not approved NMN for anything. Use that as a red-flag test.
Dose: trials used roughly 100–300 mg/day. Products far outside that range have little connection to the evidence.
In Japan, check the FOSHU registration number in the Consumer Affairs Agency database.
Avoid products whose only selling points are "high purity" or "high absorption" with nothing verifiable behind them.

Reference product links (in preparation): this page will later link to verified products. Grades will not change when links are added.

Bottom line

NMN is the archetype of "promising but unproven". The rise in blood NAD+ is near-certain; some improvement in muscle metabolism is promising but unreplicated; "rejuvenation" is marketing, not evidence. If you try it, keep the dose inside the trial range, judge effects by lab values rather than feelings, and consult your physician if you take medication.

References

Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372:1224–1229 (2021). https://www.science.org/doi/10.1126/science.abj1696
Mills KF et al. (full text of the above trial) PMC8550608
Igarashi M et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD levels and partially improves memory and physical function in older human adults. GeroScience (2022). s41514-022-00084-z
US FDA position on NMN marketing (2022) FDA: Dietary Supplements

This article is informational, not medical advice. If you have a medical condition or take medication, consult a physician.